Negar Asdaghi/LinkedIn
Oct 21, 2026, 13:52
Negar Asdaghi: Could Cilostazol Improve Hematoma Clearance After ICH
Negar Asdaghi, Professor of Neurology at University of Miami, Miller School of Medicine, Host of Stroke Alert Podcast, shared Stroke AHA/ASA’s post on X:
“Can cilostazol improve endogenous hematoma clearance after ICH?
Does a universal hold of anti platelet therapies reasonable post IVT in all?
Learn this a much more with this issue of the Stroke Alert podcast.”
Stroke AHA/ASA shared a post on X:
“The October 2026 episode of the Stroke Alert Podcast is now available.
In this episode, host Negar Asdaghi highlights articles in the October issue of Stroke and interviews Drs. Che-Feng Chang and Hsin-Hsi Tsai on ‘Cilostazol Treatment for ICH.'”
Stay updated with Hemostasis Today.
-
Oct 21, 2026, 14:08Vera Ghali: The Role of Hepcidin Assays in Diagnosing Iron Disorders
-
Oct 21, 2026, 10:33Karen Schreiber: Beyond Clinical Outcomes – The Voices of Women with APS
-
Oct 21, 2026, 10:11Tau Braun: Clots Through the Copper-Zinc Model
-
Oct 21, 2026, 09:55Cristina Figueroa Villalba: Celebrating Excellence in Transfusion Medicine
-
Oct 21, 2026, 09:43Ahmad Gharehbaghian: How Can Blood Supplies Be Sustained During a Crisis?
-
Oct 21, 2026, 09:30Adrián Dante De Angelis: Research That Opens New Possibilities for Recurrent iTTP
-
Oct 21, 2026, 09:13Jarod Horobin: Blood 2026 – Connecting Science and People
-
Oct 21, 2026, 08:35Raeeda Gheewala: VTE in Athletes – Risks Beyond the Playing Field
-
Oct 21, 2026, 08:29Andreas Kronbichler: The Changing Landscape of CV Risk in ANCA-Associated Vasculitis